找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Quality Management and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy; The JACIE Guide Mahmoud Aljurf,John A

[复制链接]
楼主: 小费
发表于 2025-3-26 23:46:03 | 显示全部楼层
发表于 2025-3-27 01:35:02 | 显示全部楼层
Personnel Requirements Including Job Descriptions,ous development of their competencies. Job descriptions for personnel should not be limiting and should support continuous professional development. In addition, accurate and frequent communication will increase cooperation within cellular therapy centres, minimise margins of error and contribute positively to patient care.
发表于 2025-3-27 06:01:16 | 显示全部楼层
发表于 2025-3-27 11:41:10 | 显示全部楼层
Tracking and Traceability,ogether will form an ‘information environment’. Together with electronic standards such as ISBT128 and Eurocode, this will further enhance safety, accuracy and efficiency in tracking and tracing cellular products.
发表于 2025-3-27 14:54:01 | 显示全部楼层
Training Programme,rocedures as well as cooperate with personnel from other disciplines. Staff training plays a key role in the implementation of cell therapy and in QM. New cell therapy applications are constantly being developed. Appropriate training of personnel will improve both the effectiveness of cell therapy and patient survival.
发表于 2025-3-27 17:52:12 | 显示全部楼层
Quality and Standards for Haematopoietic Stem Cells Transplantation Programs,transplantation professionals have been continuously developing and improving standards to help control this complexity and manage the inherent risks of this treatment. In this regard, HSCT was, and continues to be, a pioneer in the area of quality and standards.
发表于 2025-3-28 01:17:19 | 显示全部楼层
发表于 2025-3-28 04:38:39 | 显示全部楼层
Adverse Events and Corrective and Preventive Actions, in this case, the transplant programme quality system should have specific SOP that includes a system to manage any issues, actions to prevent adverse events and deviations, and a description of the step to resolve them.
发表于 2025-3-28 10:02:56 | 显示全部楼层
Risk Management,by whom, why, how, and when this approach should be applied in order to benefit the production and use of safe and effective cell-based therapies in general and hematopoietic stem cell transplantation in particular.
发表于 2025-3-28 13:49:37 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 03:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表